Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thromboembolism | D013923 | HP_0001907 | — | — | 2 | — | — | — | 2 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | 1 | 1 | — | — | — | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | — | — | — | 2 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | 1 | 1 | — | — | — | 2 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | 1 | — | — | — | 1 |
Replacement arthroplasty knee | D019645 | — | — | — | 1 | — | — | — | 1 |
Hemodiafiltration | D017583 | — | — | — | 1 | — | — | — | 1 |
Drug common name | OSOCIMAB |
INN | osocimab |
Description | Osocimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target coagulation factor XI. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297905 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | EK5V9UL3WL (ChemIDplus, GSRS) |